Viridian Therapeutics Announces Completion of THRIVE-2 Enrollment for VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED) by Seini Moimoi | Jul 25, 2024 | Portfolio News
Mirum’s LIVMARLI Now Approved for PFIC in Patients 12 Months and Older by Seini Moimoi | Jul 25, 2024 | Portfolio News
Inozyme Pharma Publishes Preclinical Data Supporting INZ-701 as a Potential Therapy for a Broad Range of Serious Rare Diseases Impacting Bone Health and Blood Vessel Function by Seini Moimoi | Jul 25, 2024 | Portfolio News
Kestra Medical Technologies Announces $196 Million Oversubscribed Financing Round by Seini Moimoi | Jul 24, 2024 | Portfolio News
Ceribell Announces Publication of Study Demonstrating Significant Reduction in Length of ICU Stays and Better Patient Outcomes with Ceribell Point-of-Care EEG Compared to Conventional EEG by Seini Moimoi | Jul 22, 2024 | Portfolio News
Sydnexis welcomes Perry J. Sternberg as Chief Executive Officer by Seini Moimoi | Jul 16, 2024 | Portfolio News
WelbeHealth Continues California Expansion with Opening of New PACE Centers in Riverside and Coachella Valley by Seini Moimoi | Jul 15, 2024 | Portfolio News
AEON Biopharma Announces Strategic Reprioritization to Pursue a Biosimilar Pathway for ABP-450 by Seini Moimoi | Jul 10, 2024 | Portfolio News
IntelyCare Appoints Industry Leader Matthew Levesque as CEO by Seini Moimoi | Jul 10, 2024 | Portfolio News
Mirum Pharmaceuticals’ LIVMARLI Approved in the European Union for Patients with PFIC by Seini Moimoi | Jul 8, 2024 | Portfolio News
